Form D — Edesa Biotech, Inc.
0001493152-26-030335 · filed Jun 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $3,500,000
- Reported amount sold
- $3,499,986
- Minimum investment
- $0
- Investors
- 4
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Edesa Biotech, Inc.
- CIK
- 1540159
- Entity
- Corporation
- Jurisdiction
- BRITISH COLUMBIA, CANADA
- Year incorporated
- —
- Address
- 100 SPY COURT
MARKHAM, A6 L3R 5H6 - Phone
- 289-800-9600
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Sean MacDonald · DirectorMarkham, A6 Find on LinkedIn ↗
-
Pardeep Nijhawan · Executive OfficerMarkham, A6 Find on LinkedIn ↗
-
Carlo Sistilli · DirectorMarkham, A6 Find on LinkedIn ↗
-
Michael Brooks · Executive OfficerMarkham, A6 Find on LinkedIn ↗
-
Peter Weiler · Executive OfficerMarkham, A6 Find on LinkedIn ↗
-
Joan Chypyha · DirectorMarkham, A6 Find on LinkedIn ↗
-
Charles Olson · DirectorMarkham, A6 Find on LinkedIn ↗
-
Patrick Marshall · DirectorMarkham, A6 Find on LinkedIn ↗
-
David Liu · DirectorMarkham, A6 Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗